154 related articles for article (PubMed ID: 6607110)
21. Aphidicolin and deoxycoformycin cause DNA breaks and cell death in unstimulated human lymphocytes.
Brox L; Hunting D; Belch A
Biochem Biophys Res Commun; 1984 May; 120(3):959-63. PubMed ID: 6428403
[TBL] [Abstract][Full Text] [Related]
22. Differential sensitivity of leukemic cells to growth inhibition by deoxyadenosine and deoxycoformycin.
Tanaka M; Kimura K
Tohoku J Exp Med; 1985 Dec; 147(4):331-41. PubMed ID: 3879563
[TBL] [Abstract][Full Text] [Related]
23. Preclinical studies on deoxycoformycin and deoxyadenosine as pharmacologic T cell purging tools.
Sheridan W; Gordon DS; Fullen AJ; Olson A; Vogler WR; Winton E
Bone Marrow Transplant; 1989 Sep; 4(5):511-7. PubMed ID: 2790329
[TBL] [Abstract][Full Text] [Related]
24. G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine.
Fox RM; Kefford RF; Tripp EH; Taylor IW
Cancer Res; 1981 Dec; 41(12 Pt 1):5141-50. PubMed ID: 6272990
[TBL] [Abstract][Full Text] [Related]
25. The effect of deoxyadenosine plus deoxycoformycin on replicative and repair synthesis of DNA in human lymphoblasts and isolated nuclei.
Matsumoto SS; Yu J; Yu AL
J Biol Chem; 1988 May; 263(15):7153-8. PubMed ID: 3259231
[TBL] [Abstract][Full Text] [Related]
26. S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.
Hershfield MS; Kredich NM; Koller CA; Mitchell BS; Kurtzberg J; Kinney TR; Falletta JM
Cancer Res; 1983 Jul; 43(7):3451-8. PubMed ID: 6601986
[TBL] [Abstract][Full Text] [Related]
27. Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complement.
Haleem A; Kurtzberg J; Olsen GA; Rhinehardt-Clark A; Leslie DS; Ray L; Smith CA; Peters WP; Haynes BF; Bast RC
Cancer Res; 1987 Sep; 47(17):4608-12. PubMed ID: 3113721
[TBL] [Abstract][Full Text] [Related]
28. 2'-Deoxycoformycin-induced hemolysis in the mouse.
Spremulli E; Crabtree GW; Dexter DL; Diamond I; Calabresi P
J Natl Cancer Inst; 1982 Jun; 68(6):1011-4. PubMed ID: 6979651
[TBL] [Abstract][Full Text] [Related]
29. Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes.
Kefford RF; Fox RM
Br J Haematol; 1982 Apr; 50(4):627-36. PubMed ID: 6978147
[TBL] [Abstract][Full Text] [Related]
30. Deoxycoformycin: neurological toxicity.
Major PP; Agarwal RP; Kufe DW
Cancer Chemother Pharmacol; 1981; 5(3):193-6. PubMed ID: 6975188
[TBL] [Abstract][Full Text] [Related]
31. [Modulation of graft versus host disease by in vitro incubation of donor cells with deoxycoformycin and deoxyadenosine].
Schofer O; Veit BC
Immun Infekt; 1987 Sep; 15(5):186-90. PubMed ID: 3315974
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the effects on cultured L1210 leukemia cells of the ribosyl, 2'-deoxyribosyl, and xylosyl homologs of tubercidin and adenosine alone or in combination with 2'-deoxycoformycin.
Cass CE; Selner M; Tan TH; Muhs WH; Robins MJ
Cancer Treat Rep; 1982 Feb; 66(2):317-26. PubMed ID: 6976834
[TBL] [Abstract][Full Text] [Related]
33. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
Webster AD; Ip H; Pereira S
Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
[TBL] [Abstract][Full Text] [Related]
34. Effect of 2'-deoxycoformycin infusion on S-adenosylhomocysteine hydrolase and the amount of S-adenosylhomocysteine and related compounds in tissues of mice.
Helland S; Ueland PM
Cancer Res; 1983 Sep; 43(9):4142-7. PubMed ID: 6603264
[TBL] [Abstract][Full Text] [Related]
35. Factors influencing the inhibition of repair of irradiation-induced DNA damage by 2'-deoxycoformycin and deoxyadenosine.
Begleiter A; Verburg L; Israels LG; Johnston JB
Cancer Chemother Pharmacol; 1992; 30(1):65-9. PubMed ID: 1586982
[TBL] [Abstract][Full Text] [Related]
36. Differential production of deoxyadenosine by human T and B lymphoblasts.
Iizasa T; Kubota M; Carson DA
J Immunol; 1983 Oct; 131(4):1776-9. PubMed ID: 6352803
[TBL] [Abstract][Full Text] [Related]
37. Purine deoxyribonucleoside induced hepatotoxicity in the mouse.
Renshaw J; Paine RM; Taylor GA; Harrap KR
Adv Exp Med Biol; 1984; 165 Pt B():363-6. PubMed ID: 6609540
[No Abstract] [Full Text] [Related]
38. Treatment of multiple myeloma with deoxycoformycin.
Belch AR; Henderson JF; Brox LW
Cancer Chemother Pharmacol; 1985; 14(1):49-52. PubMed ID: 3871175
[TBL] [Abstract][Full Text] [Related]
39. Action of deoxycoformycin on human T cell colonies in vitro.
Colledge NR; Krajewski AS; Smyth JF; Wyllie AH
Clin Exp Immunol; 1982 Oct; 50(1):115-22. PubMed ID: 6983406
[TBL] [Abstract][Full Text] [Related]
40. Adenosine-mediated killing of cultured epithelial cancer cells.
Barry CP; Lind SE
Cancer Res; 2000 Apr; 60(7):1887-94. PubMed ID: 10766176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]